Protocol Ledger

NCT04297683 · Phase II/III · ACTIVE NOT RECRUITING

HEALEY ALS Platform Trial - Master Protocol

Interventional Phase II/III clinical trial protocol NCT04297683 sponsored by Merit E. Cudkowicz, MD in Neurology, Psychiatry, and Pain, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2020-06-14 Enrollment: 1,500 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT04297683
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)1,500 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04297683
Protocol FieldVerified Registry Value
NCT IdentifierNCT04297683
Consolidated Lead SponsorMerit E. Cudkowicz, MD
Therapeutic Condition CohortNeurology, Psychiatry, and Pain
Clinical Trial PhasePhase II/III
Overall Recruitment StatusACTIVE NOT RECRUITING
Registered Enrollment1,500 participants (ESTIMATED)
Registered Start Date2020-06-14
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI